EE04277B1 - Taksoidide klassi kuuluvate derivaatide valmistamismeetod - Google Patents

Taksoidide klassi kuuluvate derivaatide valmistamismeetod

Info

Publication number
EE04277B1
EE04277B1 EEP200000155A EEP200000155A EE04277B1 EE 04277 B1 EE04277 B1 EE 04277B1 EE P200000155 A EEP200000155 A EE P200000155A EE P200000155 A EEP200000155 A EE P200000155A EE 04277 B1 EE04277 B1 EE 04277B1
Authority
EE
Estonia
Prior art keywords
derivatives
preparation
taxoid class
taxoid
class
Prior art date
Application number
EEP200000155A
Other languages
English (en)
Estonian (et)
Inventor
Didier Eric
Oddon Gilles
Pauze Denis
Leon Patrick
Riguet Didier
Original Assignee
Aventis Pharma S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma S.A. filed Critical Aventis Pharma S.A.
Publication of EE200000155A publication Critical patent/EE200000155A/xx
Publication of EE04277B1 publication Critical patent/EE04277B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D263/06—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
EEP200000155A 1997-11-18 1998-11-16 Taksoidide klassi kuuluvate derivaatide valmistamismeetod EE04277B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9714442A FR2771092B1 (fr) 1997-11-18 1997-11-18 Procede de preparation de derives de la classe des taxoides
PCT/FR1998/002432 WO1999025704A1 (fr) 1997-11-18 1998-11-16 Procede de preparation de derives de la classe des taxoides

Publications (2)

Publication Number Publication Date
EE200000155A EE200000155A (et) 2001-06-15
EE04277B1 true EE04277B1 (et) 2004-04-15

Family

ID=9513490

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200000155A EE04277B1 (et) 1997-11-18 1998-11-16 Taksoidide klassi kuuluvate derivaatide valmistamismeetod

Country Status (44)

Country Link
US (1) US5962705A (pt)
EP (1) EP1032565B1 (pt)
JP (1) JP4359386B2 (pt)
KR (1) KR100581656B1 (pt)
CN (1) CN100375744C (pt)
AP (1) AP1198A (pt)
AR (1) AR017639A1 (pt)
AT (1) ATE232855T1 (pt)
AU (1) AU755376B2 (pt)
BG (1) BG64281B1 (pt)
BR (1) BRPI9814658B8 (pt)
CA (1) CA2304833C (pt)
CO (1) CO4771105A1 (pt)
CZ (1) CZ292642B6 (pt)
DE (1) DE69811530T2 (pt)
DK (1) DK1032565T3 (pt)
DZ (1) DZ2653A1 (pt)
EA (1) EA002622B1 (pt)
EE (1) EE04277B1 (pt)
ES (1) ES2192795T3 (pt)
FR (1) FR2771092B1 (pt)
GE (1) GEP20022822B (pt)
HU (1) HU228188B1 (pt)
ID (1) ID24620A (pt)
IL (1) IL135512A (pt)
IN (1) IN191018B (pt)
IS (1) IS2272B (pt)
MA (1) MA24817A1 (pt)
MX (1) MXPA00002244A (pt)
MY (1) MY121031A (pt)
NO (1) NO325664B1 (pt)
NZ (1) NZ504125A (pt)
OA (1) OA11384A (pt)
PL (1) PL191240B1 (pt)
PT (1) PT1032565E (pt)
SI (1) SI1032565T1 (pt)
SK (1) SK283932B6 (pt)
TN (1) TNSN98207A1 (pt)
TR (1) TR200001415T2 (pt)
TW (1) TW518329B (pt)
UA (1) UA56275C2 (pt)
UY (1) UY25256A1 (pt)
WO (1) WO1999025704A1 (pt)
ZA (1) ZA9810511B (pt)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA23823A1 (fr) 1995-03-27 1996-10-01 Aventis Pharma Sa Nouveaux taxoides, leur preparation et les compositions qui les contiennent
US6372780B2 (en) 1995-03-27 2002-04-16 Aventis Pharma S.A. Methods of treating cell lines expressing multidrug resistance P-glycoprotein
US6346543B1 (en) * 1998-08-17 2002-02-12 Aventis Pharma S.A. Use of a taxoid to treat abnormal cell proliferation in the brain
US6403634B1 (en) 1999-01-13 2002-06-11 Aventis Pharma S.A. Use of taxoid derivatives
FR2859996B1 (fr) 2003-09-19 2006-02-03 Aventis Pharma Sa Solvat acetonique du dimethoxy docetaxel et son procede de preparation
FR2926551A1 (fr) * 2008-01-17 2009-07-24 Aventis Pharma Sa Formes cristallines du dimethoxy docetaxel et leurs procedes de preparation
KR101671537B1 (ko) 2008-08-11 2016-11-01 넥타르 테라퓨틱스 다분지형 중합체 알카노에이트 컨쥬게이트
AU2010310986A1 (en) 2009-10-29 2012-06-14 Aventis Pharma S.A. Novel antitumoral use of cabazitaxel
US8791279B2 (en) 2010-12-13 2014-07-29 Yung Shin Pharm. Ind. Co., Ltd. Process for preparing taxoids from baccatin derivatives using lewis acid catalyst
WO2012088433A1 (en) 2010-12-22 2012-06-28 Nektar Therapeutics Deuterated and/or fluorinated taxane derivatives
WO2012088445A1 (en) 2010-12-22 2012-06-28 Nektar Therapeutics Multi-arm polymeric prodrug conjugates of cabazitaxel-based compounds
WO2012088422A1 (en) 2010-12-22 2012-06-28 Nektar Therapeutics Multi-arm polymeric prodrug conjugates of taxane-based compounds
JP2014514306A (ja) 2011-04-12 2014-06-19 プラス・ケミカルス・エスアー 固体形態のカバジタキセル及びその製造方法
TWI526437B (zh) 2011-09-09 2016-03-21 台灣神隆股份有限公司 卡巴他賽之結晶型
CN103012329A (zh) * 2011-09-23 2013-04-03 复旦大学 一种制备紫杉醇类抗癌药Cabazitaxel XRP6258的方法
CN103012330A (zh) * 2011-09-23 2013-04-03 复旦大学 一种紫杉醇类抗癌药xrp6258的制备方法
WO2013069027A1 (en) 2011-09-26 2013-05-16 Fresenius Kabi Oncology Ltd. Processes for the preparation of cabazitaxel involving c(7) -oh and c(13) -oh silylation or just c(7) -oh silylation
CN102408397B (zh) * 2011-10-19 2014-08-20 上海贝美医药科技有限公司 紫杉烷类衍生物及其制备方法
CN102516281B (zh) * 2011-10-20 2015-02-04 江苏红豆杉生物科技股份有限公司 一种10-脱乙酰基巴卡丁iii及其衍生物甲氧基化的方法
WO2013072766A2 (en) 2011-10-31 2013-05-23 Scinopharm Taiwan, Ltd. Process for cabazitaxel and intermediates thereof
CN103159704B (zh) * 2011-12-12 2015-06-10 上海佰霖国际贸易有限公司 卡巴他赛中间体及卡巴他赛中间体的制备方法
CN103159705B (zh) * 2011-12-12 2015-05-27 福建南方制药股份有限公司 卡巴他赛中间体的制备方法
US9403785B2 (en) 2012-01-03 2016-08-02 Shilpa Medicare Limited Process for preparing amorphous cabazitaxel
CN102786502B (zh) * 2012-08-21 2014-05-14 江苏红豆杉生物科技有限公司 一种紫杉烷药物7,10-甲氧基多西他赛的合成方法
US9487496B2 (en) 2012-11-09 2016-11-08 Intas Pharmaceuticals Limited Process for the preparation of cabazitaxel and its intermediates
KR101407353B1 (ko) * 2012-12-04 2014-06-17 주식회사 삼양바이오팜 10-디아세틸바카틴 iii으로부터 카바지탁셀을 고수율로 제조하는 새로운 방법 및 이를 위한 신규 중간체
EP2743264A1 (en) 2012-12-13 2014-06-18 INDENA S.p.A. New crystalline form of cabazitaxel, process for the preparation and pharmaceutical compositions thereof
CN103012331A (zh) * 2012-12-28 2013-04-03 北京科莱博医药开发有限责任公司 卡巴他赛及其中间体的制备方法
WO2014199401A2 (en) * 2013-06-14 2014-12-18 Hetero Research Foundation Process for cabazitaxel
CN106632158B (zh) * 2013-08-28 2018-11-06 江苏恒瑞医药股份有限公司 7β,10β-二甲氧基-10-去乙酰基浆果赤霉素III的制备方法
CN103450117A (zh) * 2013-09-18 2013-12-18 江苏红豆杉药业有限公司 一种7,10-二甲氧基紫杉烷化合物的制备方法
KR101490738B1 (ko) 2013-10-15 2015-02-11 (주)한국해양기상기술 플랑크톤 검사장치
EP2865674A1 (en) 2013-10-23 2015-04-29 INDENA S.p.A. Crystalline solvate forms of Cabazitaxel
EP2865675A1 (en) 2013-10-23 2015-04-29 INDENA S.p.A. A crystalline anhydrous form of Cabazitaxel, process for the preparation and pharmaceutical compositions thereof
WO2015096553A1 (zh) * 2013-12-24 2015-07-02 于跃 抗多药耐药紫杉烷类抗肿瘤化合物及其制备方法
CN104817522A (zh) * 2015-04-01 2015-08-05 江苏红豆杉药业有限公司 一种7,10-二甲氧基-10DabⅢ的合成方法
WO2020249507A1 (en) 2019-06-11 2020-12-17 Indena S.P.A. Anhydrous crystalline form of cabazitaxel, a process for its preparation and pharmaceutical compositions containing it

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3927118A (en) * 1973-12-21 1975-12-16 Crown Zellerbach Corp Process for monoetherification of polyhydric benzenes
EP0304244A3 (en) * 1987-08-18 1990-01-10 Takeda Chemical Industries, Ltd. Propanediol derivatives, their production and use
US5175315A (en) * 1989-05-31 1992-12-29 Florida State University Method for preparation of taxol using β-lactam
FR2696459B1 (fr) * 1992-10-05 1994-11-25 Rhone Poulenc Rorer Sa Procédé de préparation de dérivés du taxane.
TW467896B (en) * 1993-03-19 2001-12-11 Bristol Myers Squibb Co Novel β-lactams, methods for the preparation of taxanes and sidechain-bearing taxanes
GB9405400D0 (en) * 1994-03-18 1994-05-04 Erba Carlo Spa Taxane derivatives
EP0757695A1 (en) * 1994-04-28 1997-02-12 Allelix Biopharmaceuticals Inc. Guanidino-substituted compounds
IT1274250B (it) * 1995-02-21 1997-07-15 Himont Inc Dieteri utilizzabili nella preparazione di catalizzatori ziegler-natta
MA23823A1 (fr) * 1995-03-27 1996-10-01 Aventis Pharma Sa Nouveaux taxoides, leur preparation et les compositions qui les contiennent
US5688977A (en) * 1996-02-29 1997-11-18 Napro Biotherapeutics, Inc. Method for docetaxel synthesis

Also Published As

Publication number Publication date
WO1999025704A1 (fr) 1999-05-27
CN100375744C (zh) 2008-03-19
AP2000001816A0 (en) 2000-06-30
IS5471A (is) 2000-04-26
IL135512A0 (en) 2001-05-20
HUP0100519A1 (hu) 2001-06-28
AR017639A1 (es) 2001-09-12
US5962705A (en) 1999-10-05
IN191018B (pt) 2003-09-13
FR2771092A1 (fr) 1999-05-21
EA002622B1 (ru) 2002-06-27
KR20010032138A (ko) 2001-04-16
TR200001415T2 (tr) 2001-01-22
MY121031A (en) 2005-12-30
DK1032565T3 (da) 2003-06-02
OA11384A (fr) 2004-01-27
SI1032565T1 (en) 2003-06-30
BRPI9814658B8 (pt) 2021-05-25
KR100581656B1 (ko) 2006-05-23
CZ292642B6 (cs) 2003-11-12
CO4771105A1 (es) 1999-04-30
SK7102000A3 (en) 2000-11-07
SK283932B6 (sk) 2004-05-04
NO20002443L (no) 2000-05-11
CA2304833C (fr) 2007-03-27
NO325664B1 (no) 2008-07-07
ZA9810511B (en) 1999-05-25
HUP0100519A3 (en) 2002-09-30
JP2001523673A (ja) 2001-11-27
NZ504125A (en) 2002-10-25
IS2272B (is) 2007-07-15
CN1270586A (zh) 2000-10-18
PL191240B1 (pl) 2006-04-28
EA200000539A1 (ru) 2000-12-25
FR2771092B1 (fr) 1999-12-17
MXPA00002244A (es) 2002-04-24
BRPI9814658B1 (pt) 2016-07-19
HU228188B1 (en) 2013-01-28
TNSN98207A1 (fr) 2005-03-15
ATE232855T1 (de) 2003-03-15
DE69811530T2 (de) 2003-10-02
AU755376B2 (en) 2002-12-12
UY25256A1 (es) 2001-08-27
EE200000155A (et) 2001-06-15
CZ20001789A3 (cs) 2000-11-15
ID24620A (id) 2000-07-27
BG64281B1 (bg) 2004-08-31
EP1032565B1 (fr) 2003-02-19
EP1032565A1 (fr) 2000-09-06
PL340579A1 (en) 2001-02-12
TW518329B (en) 2003-01-21
BG104455A (en) 2001-02-28
UA56275C2 (uk) 2003-05-15
MA24817A1 (fr) 1999-12-31
DZ2653A1 (fr) 2003-03-15
AU1242299A (en) 1999-06-07
AP1198A (en) 2003-08-27
ES2192795T3 (es) 2003-10-16
BR9814658A (pt) 2000-10-03
JP4359386B2 (ja) 2009-11-04
PT1032565E (pt) 2003-07-31
IL135512A (en) 2004-06-20
DE69811530D1 (de) 2003-03-27
NO20002443D0 (no) 2000-05-11
CA2304833A1 (fr) 1999-05-27
GEP20022822B (en) 2002-10-25

Similar Documents

Publication Publication Date Title
EE04277B1 (et) Taksoidide klassi kuuluvate derivaatide valmistamismeetod
ATE260243T1 (de) N-aroylphenylalaninderivate
ATE235220T1 (de) Resorcinderivate
ID22781A (id) Turunan-turunan nikotinamida
DE69817186D1 (de) Diaminorhodamin-derivate
PT1000048E (pt) Derivados substituidos do 1,2,3,4-tetrahidronaftaleno
IT1315269B1 (it) Metodo per la preparazione di 5-cianoftalide
NO20000231D0 (no) Dolastatin-15-derivater
EE200000140A (et) Asendatud kromaani derivaadid
PT921125E (pt) Derivados de 1,38-triaza-espiro 4,5 decan-4-ona
EE200000144A (et) Asendatud kromaani derivaadid
DE69841086D1 (de) 5-Deoxy-Cytidin-Derivate
TR199800403A3 (tr) a-Bromo-laktam türevlerinin hazirlanmasi için yöntem.
DE69829682D1 (de) Cis-disubstituierte aminocycloalkyl-pyrrolidin-derivate
MA26480A1 (fr) Derives de phenoxymethylpiperidine
DE69828780D1 (de) Amidinocamptpthecin-derivate
DK0966437T3 (da) 5-Aroylnaphthalenderivater
NO996432D0 (no) Fremgangsmåte for fremstilling av 4-substituert-1H-indol-3- glykosamider
TR199800068A3 (tr) Benzofenon türevlerinin hazirlanmasina yönelik metodlar.
DK1015447T3 (da) Piperidinylmethyloxazolidinonderivat
EE9900404A (et) Arüülaminotriasolopüridiinide valmistamise meetod
NO20003077L (no) FremgangsmÕte for fremstilling av klorbenzooksazolen
NO20013044D0 (no) Fremgangsmåte for fremstilling av NG-substituerte deaza- adenosinderivater
NO20002476L (no) FremgangsmÕte for fremstilling av formylimidazoler
BR9704770A (pt) Derivados de 1-carba-(detia)-cefalosporina

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20101231